Dopamine transporter density by [99mTc]-TRODAT-1 SPECT and neurocognitive performance - a preliminary pilot study

Shih, Ming; Amaro, Edson Junior; Souza, Sayuri de E; Pupo, Mariana C; Malta, Stella M; Hoexter, Marcelo Q; Garrido, Griselda J; Bueno, Orlando A; Ferraz, Henrique; Goulart, Fabricio O; Wagner, Jairo; Lin, Li F; Fu, Ying K; Lacerda, Acioly T; Bressan, Rodrigo A.
Rev. med. nucl. Alasbimn j ; 8(33)julio 2006.
Artículo en Inglés | LILACS | ID: lil-444097

Documentos relacionados

  1. Cognition in Patients With a Clinical Diagnosis of Parkinson Disease and Scans Without Evidence of Dopaminergic Deficit (SWEDD): 2-Year Follow-Up.
  2. Mepirapim, a novel synthetic cannabinoid, induces Parkinson's disease-related behaviors by causing maladaptation of the dopamine system in the brain.
  3. Cerebral dopamine deficiency, plasma monoamine alterations and neurocognitive deficits in adults with phenylketonuria.
  4. Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance.
  5. The dopaminergic system dynamic in the time perception: a review of the evidence.
  6. Cognitive effects of dopamine depletion in the context of diminished acetylcholine signaling capacity in mice.
  7. 123I-FP-CIT SPECT [(123) I-2ß-carbomethoxy-3ß-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's disease.
  8. Unusual dopaminergic depletion in variant Creutzfeldt-Jakob disease with early and rapid cognitive decline.
  9. Cortical and Striatal Astrocytes of Neonatal Rats Display Distinct Molecular and Pharmacological Characteristics of Dopamine Uptake.
  10. Functional brain imaging of cognitive dysfunction in Parkinson's disease.